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Abstract 
Congestive heart failure (CHF) is a chronic condition that requires daily management by those 
affected. Readmission and mortality rates are high for congestive heart failure patients (Yancy et 
al., 2013).  Additionally, CHF affects the health related quality of life (HRQOL) experienced by 
those impacted (Yancy et al., 2013).  The health care costs for treatment, hospital readmissions, 
and management of CHF are very expensive and they are a burden to the health care system 
(Yancy et al., 2013).  Current strategies to increase patient self-management of CHF have not 
proven sufficient to lower the rate of readmissions and the associated costs (Bradley et al., 2012).  
In addition to the current methods used to decrease readmission rates, the Daily Checklist should 
be given to patients upon diagnosis of CHF or before discharge from the hospital. The Daily 
Checklist which includes medications, exercise, daily weight, and sodium (salt) will help patients 
remember what steps they must take each day to control their CHF, reduce their symptoms, and 
prevent readmissions for exacerbations. This will increase the patient’s self-efficacy (confidence) 
in their ability to manage their CHF on their own and activate their motivation to perform self-
care behaviors (Shively et al., 2013). The expected outcome of the Daily Checklist is increased 
self-efficacy and self-management of CHF, decreased hospital readmissions and early mortality, 
and reduced health care costs associated with managing CHF patients.  
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Daily Checklist: A Visual Aid to Increase Self-Efficacy in Congestive Heart Failure Patients 
Introduction  
 Congestive heart failure (CHF) increases a person’s risk for hospital admission and 
mortality. Each year over 650,000 new cases of CHF are diagnosed. Mortality rates for those 
with CHF are approximately 50% within 5 years of diagnosis (Yancy et al., 2013). From 1993 to 
2005 post discharge mortality rates rose from 4.3% to 6.3% (Yancy et al., 2013). As the United 
States (U.S.) shifts toward an older demographic population the number of people living with 
heart failure will also increase (Yancy et al., 2013). One in nine death certificates mention heart 
failure and approximately 75 of all cardiovascular deaths are due to CHF (Yancy et al., 2013). 
This information highlights the need to improve strategies that will allow patients to cope with 
their CHF in order to prevent early mortality caused by poor self-management.  
Over one million people are admitted to the hospital each year with the primary diagnosis 
of heart failure (Yancy et al., 2013). CHF is also the number one reason for hospitalization in 
persons over the age of 65 in the United States (Lambrinou, Kalogirou, Lamnisos, & Sourtzi, 
2012). Visits to primary care providers due to CHF in 2013 cost 1.8 billion dollars (Yancy et al., 
2013). One alarming statistic is that one fourth of all patients hospitalized for heart failure are 
readmitted within 30 days. The estimated cost from Medicare reimbursement for hospital 
readmissions is 17 billion dollars yearly (Bradley et al., 2012). The total cost of CHF in America 
is over 30 billion dollars annually. This figure includes the cost of medications, health care 
services, and loss of productivity (Yancy et al., 2013). One study found that CHF readmissions 
were common after a patient was first diagnosed, 83% of patients were hospitalized once and 
43% were hospitalized at least 4 times (Yancy et al., 2013). Treatment for CHF exacerbations is 
very costly. High readmission rates following discharge show that there is a need for a different 
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solution to prevent the readmission of CHF patients (Bradley et al., 2012). Current solutions 
include: patient centered discharge teaching, follow-up telephone calls, patient education on 
medications, increased coordination between hospitals and primary care providers, and home 
visits (Bradley et al., 2012). While these strategies should be continued in an effort to decrease 
readmission rates, mortality rates, and the financial burden on the health care system they are not 
sufficient on their own. Therefore, additional strategies are also needed (Bradley et al., 2012).   
In conjunction with the current methods to reduce high CHF readmission rates, a visual 
aid should be given to each patient upon discharge to act as a reminder about what they can do to 
manage their chronic disease. The Daily Checklist will allow patients to indicate, throughout the 
day, if they have taken their CHF medications, exercised, weighed themselves, and how much 
sodium they have consumed. The checklist will ideally be located somewhere in the patient’s 
home that they visit frequently throughout the day, such as on the refrigerator. By placing the 
Daily Checklist in a frequently visited area of their home this will allow for maximum daily 
exposure to help increase the patient’s self-efficacy (confidence) in managing their CHF.  
Background 
There are several factors that increase an individual’s risk of developing CHF. African 
Americans who are forty years of age or older have a 20% chance of developing CHF during 
their life (Yancy et al., 2013). Caucasian women have the lowest incidence of CHF and African 
American men have the highest incidence (Yancy et al., 2013). CHF prevalence in African 
American males and females is 4.5% and 3.8% respectively; CHF in Caucasian males and 
females is 2.7% and 1.8% respectfully (Yancy et al., 2013).  African Americans have a higher 5 
year mortality rate than Caucasians (Yancy et al., 2013).  The incidence of developing CHF 
increases with age. Approximately 5.1 million people in the United Sates have clinical 
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manifestations of CHF and this number is increasing. Those who are eligible for Medicare have 
had an increase in the prevalence of CHF from 9% in 1994 to 12.1% in 2003 (Yancy et al., 
2013). By 2050 one in five Americans will be age 65 or older. Since the prevalence of CHF is 
highest in this population the number of Americans suffering from CHF is expected to increase 
(Yancy et al., 2013).  
As mentioned previously, CHF is a condition most often found in adults over the age of 
65 (Hallerbach et al., 2008). The prevalence of CHF increases as a person ages and the risk of 
developing CHF doubles each decade over age 65 (Gallegher, 2010).  Research has found that 
there are several factors that can predict a patient’s susceptibility for readmission after discharge 
from the hospital for CHF.  One predictor is multiple comorbidities that can be measured through 
the Charlson Comorbidity Index. Other predictors include: noncompliance with medications, 
diet, and exercise, medication discrepancies such as a change in medications from pre-
hospitalization to post hospital discharge,  the lack of a cardiology consult during admission to 
the hospital, receiving Medicare, living alone, and also having pulmonary hypertension 
(Hallerbach et al., 2008). 
CHF can severely impact a patient’s health related quality of life (HRQOL) and 
functional status. When HRQOL does not improve for patients their chances of readmission and 
mortality are increased (Yancy et al., 2013).  Men with CHF have a better HRQOL than women 
with CHF. Other factors that contribute to a poorer HRQOL include: younger age, higher BMI, 
depression, lower systolic blood pressure, greater symptom burden, low perceived control, sleep 
apnea, and uncertainty about prognosis (Yancy et al., 2013). Problems with memory can also 
lead to poorer HRQOL. Currently the only therapies that have been found to improve HRQOL 
are cardiac resynchronization therapy (pacemaker implantation) and disease management and 
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education approaches. Self-care and exercise may improve HRQOL. HRQOL is an important 
factor determining readmissions to the hospital for exacerbations and increased risk for 
mortality. Since increased self-care by the patient and exercise can improve HRQOL it is 
important that these interventions are taught to the patient as key factors for managing their 
illness (Yancy et al., 2013). The goal of the Daily Checklist is to improve the patient’s ability to 
perform self-care activities, one of which is exercise. Therefore, by giving the checklist to 
patients they will be less likely to be readmitted to the hospital and have early mortality due to 
their CHF.  
Literature Review 
In order to understand CHF it is important to know the pathophysiology behind the 
condition, how major geriatric syndromes make it difficult for patients to manage their CHF, and 
how patient noncompliance can lead to increased hospital readmissions and mortality. It is also 
necessary to understand the current recommendations by The American College of Cardiology 
Foundation/ American Heart Association Task Force (ACCF/AHA) as well as other credible 
sources concerning medications, exercise, daily weight management, and sodium restrictions. To 
understand why the Daily Checklist is important it is also imperative to comprehend how 
external memory aids and mnemonics increase the likelihood of a patient performing self-
management strategies.  
Congestive Heart Failure Pathophysiology 
CHF occurs due to structural or functional impairment of ventricular filling or the 
ejection of blood. Clinical manifestations include dyspnea and fatigue (Yancy et al., 2013). CHF 
“may result from disorders of the pericardium, myocardium, endocardium, heart valves, great 
vessels, or due to certain metabolic abnormalities, but most patients with heart failure (HF) have 
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symptoms due to impaired left ventricular (LV) myocardial function” (Yancy et al., 2013, p. 
246- 247). 
Major Geriatric Syndromes 
One study found that patients who presented to the hospital with at least one major 
geriatric syndrome (MGS) had an increased risk for 12-month mortality and readmission 
following discharge. This study defined major geriatric syndromes as having one of the 
following conditions: cognitive impairment, severe functional dependence, depression, or frailty 
upon admission. Other geriatric conditions that were also analyzed were mobility impairment, 
recurrent falls, urinary incontinence, hearing and visual impairments, as well as coexisting acute 
diseases (Sanchez, Vidan, Serra, Fernandez-Aviles, & Bueno, 2011). This study went on to find 
that having at least one MGS on admission in conjunction with CHF was associated with a 
greater chance of not only readmission but also, functional decline, and a need for more social 
support 12 months after discharge (Sanchez et al., 2011). As one ages they are more at risk for 
MGSs and since most patients diagnosed with CHF are over the age of 65 they are a population 
who is at increased risk for having MGSs in concurrence to their diagnosis of CHF. MGSs can 
affect the ability of the patient to manage their CHF and thus they can be a factor in the high 
readmission rates in the CHF population.  
Noncompliance 
Noncompliance with their medical treatment plan is a leading factor for high 
readmissions and it can be prevented (Lambrinou et al., 2012). Comprehensive discharge 
planning which includes education and information on transition care are key components of 
enabling the patient to take control of their health (Lambrinou et al., 2012).  Discharge planning 
and teaching is not consistent across facilities or even units within the same facility. Also, 
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teaching is often not tailored to each patient’s individualized risk factors for readmission. 
Discharge teaching can also be rushed due to the need for an open room for a new admission or 
due to the patient’s wishes to go home as soon as possible. These factors can cause the patient to 
receive inadequate information on how to manage their CHF once they are out of the hospital 
therefore, leading to an increased risk of the patient being readmitted for a CHF exacerbation 
(Hallerbach et al., 2008). 
In order to reduce factors that influence readmission rates such as noncompliance with 
disease management routines, education provided to patients needs to come in multiple forms. 
Different forms could include video, oral, written, or role playing (Hallerbach et al., 2008). It is 
important to involve the patient in the planning process to improve the likelihood of their 
involvement in the treatment plan and to determine what learning style they prefer (Inott & 
Kennedy, 2011). Education given to the patients should explain how, to manage their CHF and 
how by following their treatment plan they can expect to see a reduction in their CHF symptoms. 
Patients should feel empowered by the education they receive and understand that they play a 
key role in preventing exacerbations and reducing their symptoms because adult learners are 
motivated by their personal “need to know” information (Inott & Kennedy, 2011). Adult learners 
must be able to understand how the information about managing their CHF relates to the 
symptoms they experience in order to feel as though their disease is manageable and that they 
have control over their disease (Inott & Kennedy, 2011). It is also important to note that the 
educator should assess the patients reading level before selecting materials for them to take home 
about managing their illness. The average American reads at an eighth to ninth grade reading 
level. One in five Americans reads at a fifth grade level or lower. Education level does not reflect 
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literacy. Therefore, all materials designed for patients should be at or below a fifth grade reading 
level (Inott & Kennedy, 2011). 
As mentioned previously, effective teaching must elicit activation of the patient’s self-
efficacy (motivation) to perform self-management tasks. It is imperative to identify interventions 
that assist those with CHF to practice optimal self-management strategies due to the progressive 
nature of the disease, the costs of readmission, the risk for early mortality, and the impact CHF 
has on their HRQOL (Gallegher, 2010).   Patient activation is defined as having the information, 
behavioral skills, and motivation that is necessary to manage a chronic illness, access appropriate 
care, maintain functioning, and collaborate with healthcare providers (Shively et al., 2013). 
Providing new ideas on ways to increase patient activation as it pertains to disease management 
and self-efficacy is a promising direction that could possibly improve outcomes for CHF care 
(Shively et al., 2013). A key component to patient activation is self-efficacy which can be 
defined as the confidence the patient has in their abilities to develop skills that will allow them to 
manage their CHF. Patients who have a confidence in their ability to manage their disease are 
more likely to consistently follow their management regimes, even when the demands of the 
disease are chronic and increase over time (Gallegher, 2010).  
 One study found that the self- care behaviors most frequently reported by patients with 
CHF included: exercising, following a low sodium diet, daily weights, and taking their 
medications (Barnason, Zimmerman, Young, 2011). This study revealed that patients who 
performed self-management skills routinely in response to signs and symptoms had fewer 
hospital readmissions. For example, increasing weight led to actions such as taking an extra 
diuretic pill (Barnason, 2011). The study determined that the factors that could adversely impact 
self-care were the patients’ psychosocial status (depression, lower self-efficacy, less formal 
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education etc.), having an increased number of symptoms, lower health literacy, age related 
changes (cognitive and sensory impairments, reduced functioning), and less experience 
navigating the healthcare system (Barnason, 2011). It was also determined that there were factors 
that could increase self-care. These factors included: increased levels of mental and physical 
functioning, social support, and higher levels of education (Barnason, 2011). When determining 
ways to increase patient self-efficacy and disease management it is important to tailor the 
intervention to the unique needs of the client and determine the factors that can help promote and 
adversely affect their ability to manage their CHF.  
ACCF/AHA Recommendations 
 Literature shows that the key components of managing heart failure include: medications, 
exercise, daily weighing, and reducing the amount of sodium in the patient’s diet (Group Health 
Cooperative, 2014). The American College of Cardiology Foundation/ American Heart 
Association Task Force (ACCF/ AHA) classifies CHF patients based on risk factors and cardiac 
structural abnormalities. There are four categories (A, B, C, and D). Progression to the next stage 
indicates a higher risk of mortality in the next 5 years and an increase in plasma natriuretic 
peptide concentrations. The stage the patient falls into determines the recommendations for their 
treatment (Yancy et al., 2013). 
Stage A. Patients in Stage A heart failure are recommended to take medications to reduce 
hypertension and disorders that cause elevated lipids (Yancy et al., 2013). Drug therapy that has 
been recommended for this group to control hypertension includes: diuretics, angiotensin-
converting enzyme inhibitors (ACE inhibitors), angiotensin II receptor blockers (ARBs), and 
beta blockers. To treat elevated lipid levels, cholesterol lowering medications, often referred to 
as statins, are recommended.  ACE inhibitors are also recommended (Yancy et al., 2013). 
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Patients in this stage are also recommended by the ACCF/ AHA to consume less than 1,500 mg 
of sodium per day (Yancy et al., 2013). 
 Stage B. Patients in Stage B are recommended to be on an ACE inhibitor. If they cannot 
tolerate an ACE inhibitor then ARBs are recommended to prevent symptomatic CHF and to 
reduce the mortality risk. Anyone in Stage B heart failure who has a history of myocardial 
infarction (MI) or acute coronary syndrome (ACS) which reduces blood flow to the heart and 
reduces their ejection fraction (EF) should be on a beta blocker(s) to decrease their risk for 
mortality. Also, patients in this stage who have a history of MI or ACS should be placed on a 
statin to prevent cardiovascular events such as future MIs and to prevent symptomatic CHF. 
ACE inhibitors or ARBs and beta blockers are recommended for all patients with a reduced EF 
to prevent symptomatic CHF. Diuretics and calcium channel blockers may also be indicated for 
patients in Stage B (Yancy et al., 2013). Patients classified in this stage may need an implantable 
cardioverter defibrillator (ICD) to prevent sudden cardiac death (Yancy et al., 2013). Patients in 
this stage of CHF are also recommended by the ACCF/ AHA to consume less than 1,500 mg of 
sodium per day (Yancy et al., 2013). 
 Stage C. CHF patients categorized as Stage C have some of the same drug therapy 
treatment recommendations as those classified in Stages A and B. Diuretics are strongly 
recommended for Stage C CHF patients with a reduced or normal EF. ACE inhibitors are 
recommended or an ARB if they do not respond to ACE inhibitors. An ARB may also be added 
in conjunction to an ACE inhibitor and beta blocker for those who are symptomatic with or 
without a reduced EF (Yancy et al., 2013). Beta blockers are recommended for CHF patients 
who are currently or have previously been symptomatic and who do or do not have a reduced EF. 
Aldosterone receptor antagonists are recommended for patients in this stage who have had an MI 
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and now have an EF of 40% or less and those that have diabetes mellitus (Yancy et al., 2013). 
African American patients should be prescribed hydralazine and isosorbide dinitrate if they have 
CHF and a reduced EF. Hydralazine and isosorbide dinitrate are also indicated for patients with 
symptomatic CHF and reduced EF who cannot take ACE inhibitors or ARBs due to hypotension, 
drug intolerance, or renal insufficiency (Yancy et al., 2013). Digoxin can be prescribed for CHF 
patients with a reduced EF. Patients with CHF who have atrial fibrillation are recommended to 
take an anticoagulant to prevent cardioembolic strokes. Statins are not beneficial at this stage if 
they are prescribed solely due to a CHF diagnosis. Calcium channel blockers are also not 
recommended for routine treatment of Stage C CHF. Omega-3 polyunsaturated fatty acid 
supplements are recommended for patients with or without a reduced EF (Yancy et al., 2013). 
Patients in Stage C CHF should receive education regarding the self- management of 
their CHF. This education should include how to restrict their sodium, monitor their weight and 
symptoms, take their medications, and ways to stay physically active (Yancy et al., 2013). There 
are not specific recommendations by the ACCF/ AHA about how much sodium a person in Stage 
C CHF should have. However, the ACCF/ AHA states that clinicians should consider 
recommending that sodium be restricted to less than 3,000 mg per day (Yancy et al., 2013). The 
ACCF/ AHA also recommend that patients with CHF should participate in regular physical 
activity to improve their functional status. They also state that cardiac rehabilitation in stable 
patients can improve their level of functioning, HRQOL, ability to exercise longer, and decrease 
their risk of mortality and hospitalization (Yancy et al., 2013). Continuous positive airway 
pressure (CPAP) can be helpful in patients with a decrease left ventricular EF who have sleep 
apnea (Yancy et al., 2013). At this point in the disease process an implantable cardioverter 
defibrillator (ICD) or cardiac resynchronization therapy (CRT) may be recommended for those 
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patients who meet the criteria for such devices (Yancy et al., 2013). Cardiac revascularization 
may also be needed for those who meet specific criteria (Yancy et al., 2013). 
 Stage D. In this stage of congestive heart failure patients have severe symptoms despite 
the use of maximum treatment efforts mentioned for stages A, B, and C. These patients are 
recommended to receive short term intravenous inotropic medications when hospitalized. Long 
term treatment with intravenous inotropic medications is only indicated for palliative care 
purposes. These patients should be on fluid restrictions of 1.5-2 per day. As with Stage C CHF, 
Stage D also does not have specific recommendation by the ACCF/ AHA for how much of a 
sodium restriction the patient should be on. However, like Stage C the ACCF/ AHA recommends 
the clinician consider instructing their patient in Stage D to consume less than 3,000 mg of 
sodium per day (Yancy et al., 2013). These patients are recommended to receive mechanical 
circulatory support if they are expected to recover or have a planned cardiac transplant. 
Ultimately, cardiac revascularization or transplantation is needed at this stage of CHF to prevent 
mortality (Yancy et al., 2013).  
 The AACF/ AHA also recommend that certain information be discussed with all CHF 
patients during hospitalization, before discharge, and at all follow up visits. The first 
recommendation is to initiate guideline directed medical therapy which are the recommendations 
made by the AACF/ AHA. The second recommendation is to discuss precipitating factors to 
CHF, barriers that could impact the patient’s transition to caring for themselves on their own, 
and any issues with post-discharge support. Next the patient’s volume status should be assessed 
along with assessing for orthostatic hypotension. The clinician should titrate the patient’s 
medications to optimize their benefits and assess renal function and electrolyte balances. 
Comorbidity conditions should also be assessed. The clinician must also reinforce education on 
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CHF, what the patient needs to do to manage their care, the importance of adherence to their 
CHF management plan, and what to do in emergency situations. Those patients who are 
candidates for palliative care should be informed about this service. Finally, it is recommended 
that those who are at high risk for hospital readmission should be followed by a multidisciplinary 
team and become enrolled in a disease-management program (Yancy et al., 2013). 
Medication Recommendations 
The ACCF/ AHD recommendations thoroughly describe medications that are prescribed 
to patients at each stage of CHF. Similarly, other articles show that the medications mentioned in 
the ACCF/ AHA recommendations are appropriate for CHF patients. MedlinePlus not only 
describes the medications that CHF patients may be prescribed but it also gives a simple 
description as to what they do to control a patient’s CHF and common side effects.  The article 
describes that some medications may only be prescribed to be taken once daily while others 
could be needed two or more times per day. It also advises patients to take their medications at 
the time prescribed by their doctor and to never stop taking their medications, alter their dosage, 
or start taking any new medications without consulting their doctor first (National Institutes of 
Health [NIH], 2013).  The first medications mentioned are ACE inhibitors and ARBS. These 
medications work by opening up blood vessels which helps lower blood pressure (NIH, 2013). 
Beta blockers are also listed, which act to slow down the heart rate and decrease the forces used 
by the heart to contract. Diuretics help to rid the body of excess fluid. The article also advises 
that regular blood work will need to be taken while on a diuretic to measure kidney function and 
potassium levels. Some patients with heart disease may be prescribed aspirin or Plavix to prevent 
blood clots from forming that can cause a stroke or MI. Another drug that can be prescribed to 
prevent blood clots is Warfarin. Less commonly used drugs for heart failure include: digoxin, 
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which increases the hearts contractility while reducing pulse rate, hydralazine and nitrates to 
open arteries up, and calcium channel blockers to control blood pressure or angina (NIH, 2013).   
Exercise Recommendations 
The AACF/ AHA do not have specific exercise guidelines for patients with CHF (Yancy 
et al., 2013). They do mention that regular physical activity is recommended and that cardiac 
rehabilitation can be beneficial to CHF patients (Yancy et al., 2013). However, “American Heart 
Association Recommendations for Physical Activity in Adults” includes specific 
recommendations for physical activity for all adults (American Heart Association, 2013). At 
least 30 minutes of moderate-intensity aerobic activity five days a week is recommended. 
Another option is at least 25 minutes of vigorous aerobic activity three days per week coupled 
with moderate to high intensity muscle training activities two days per week (American Heart 
Association, 2013). To lower cholesterol and blood pressure the recommendation is to exercise 
40 minutes three to four times a week performing moderate to vigorous intensity exercise 
(American Heart Association, 2013). These are substantial goals for CHF patients especially 
those who are symptomatic. The recommendations state however, that you can still receive 
benefits by splitting the exercise periods into 10-15 minute segments throughout the day to 
accomplish the total recommended amount of exercise. They also offer motivation by saying that 
even exercising a little bit is better than doing nothing at all and that with consistent effort the 
amount of time one can exercise will increase (American Heart Association, 2013). 
 The Heart Failure Society of America has their own exercise recommendations 
specifically for people with CHF. They recommend that one should consult their physician 
before starting an exercise program. The goal for most people with CHF is to be active for at 
least 30 minutes each day. The 30 minutes of activity does not have to be done in one specific 
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period of time; it can be broken down into small increments (Heart Failure Society of America, 
2006). When starting an exercise routine the patient should move at a pace that they are 
comfortable with. One can start out exercising as little as 5 minutes and increase the amount of 
time as they build up their endurance (Heart Failure Society of America, 2006). The 
recommendations also include warming up before exercising and cooling down after exercise. It 
also advocates strength training exercises using elastic bands.  
The Heart Failure Society of America warns patients that they should not choose to be 
more active on days they are experiencing increased CHF symptoms, feel exhausted, have a 
fever or are sick, have chest pain, or are changing their medications (Heart Failure Society of 
America, 2006). Signs of overexertion are also mentioned including: shortness of breath even 
once activity is stopped, dizziness or lightheadedness; chest pain radiating to arms, shoulders, 
neck, or jaw; irregular pulse rate; unusually severe sweating; and nausea or vomiting. More 
recommendations for activity include: allowing periods of rest during exercise, using slow fluid 
movements during exercise, avoiding activities that need quick bursts of energy, using good 
body mechanics, avoiding activities when it is very hot or hold, and avoiding activities right after 
a meal (Heart Failure Society of America, 2006). 
The recommendations also address sexual activity in people with CHF. They recommend 
to teach patients to talk openly with their partner about sex, to pick a time for sex when they feel 
rested, avoid having sex after a large meal or drinking alcohol, have sex in a room that is not too 
hot or cold, use foreplay to help the heart get used to increased exertion experienced during 
intercourse, avoid positions that require them to support themselves with their arms, and use 
positions that are less strenuous (Heart Failure Society of America, 2006). 
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Daily Weight 
Patients with CHF are recommended to take their weight daily. The ACCF/ AHA 
recommend patients weigh themselves daily (Yancy et al., 2013).  The recommendations do not 
however include parameters to instruct the patient as to when to call their health care provider 
regarding weight changes. Most recommendations related to CHF identify daily weighing as an 
important part of self-management. One article explains that daily weighing is an important part 
of self-management because the patient is the best person to pick up on slight changes in their 
health status that may require further investigation from their health care provider (Gallegher, 
2010). Others have recommended specific guideline parameters for patients to follow as it 
pertains to monitoring their weight. Once such guideline commonly used is that if a patient gains 
2 to 3 pounds in 24 hours or 5 pounds or more in a week then they should contact their 
healthcare provider immediately because they are retaining fluid (Group Health Cooperative, 
2014). Other resources give even more direction to patients as it pertains to weighing themselves 
daily. MedlinePlus advises CHF patients to weigh themselves in the morning, using the same 
scale, before they eat and after they use the restroom  (National Institute of Health [NIH], 
2012a).They also advise wearing similar clothing each time one weighs themselves and writing 
the weight down every day so the patient can keep track of any fluctuations. In addition to 
recommending that patients call their healthcare provider if they gain 2 to 3 pounds in one day or 
5 pounds in one week, they also recommend calling if a patient loses “a lot of weight” (NIH, 
2012a).  
Sodium Restrictions 
 As mentioned previously, patients who are diagnosed with heart failure should be on a 
low-sodium diet. The ACCF/ AHA recommend that patients in Stages A and B consume no 
DAILY CHECKLIST  18 
 
more than 1,500 mg of sodium per day. However, the ACCF/ AHA suggests it may be beneficial 
for patients in Stages C and D to limit their sodium intake to less than 3,000 mg per day but that 
there is not enough evidence to support an exact recommendation for these patients (Yancy et al., 
2013).  One article found in an academic journal data base suggests that there is new research 
supporting that 1,500 mg of sodium per day should be the target for populations at risk for 
cardiovascular disease (Lennie, Chung, & Moser, 2013). The Heart Failure Society of America 
recommends 2,000-3,000 mg of sodium per day and The Dietetic Association recommends less 
than 2,000 mg of sodium per day (Lennie, Chung, & Moser, 2013).  
For patients to effectively follow a low sodium diet, they must be informed about what 
their target goal of sodium is and how to obtain this information through the nutritional labels on 
the food they consume (Lennie, Chung, & Moser, 2013). The lack of evidence to support an 
exact amount of sodium that is appropriate for patients in classes C and D could lead to 
confusion not only from providers but also from patients suffering from CHF. Confusion can 
also arise in patients when they are told to follow a low sodium diet but are not shown how to 
properly read nutritional labels on the foods they eat (Lennie, Chung, & Moser, 2013). When 
considering that in order to read the food labels the patient must be literate and have basic math 
skills to calculate the daily total another barrier to compliance to a low sodium diet is recognized. 
An article written by Son, Lee, and Song, noted that there is a lack of consensus as to how to 
instruct patients to follow a low sodium diet (Son, Lee, & Song, 2011). They determined that 
patients do not understand the correlation between a high sodium diet and worsening of their 
symptoms. This highlights the need to inform patients of the correlation and empower them to 
take control over the factors that exacerbate their symptoms of CHF. This also once again cites 
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that one reason patients have trouble following a low sodium diet is that they do not understand 
the sodium content in the foods they eat (Son, Lee, & Song, 2011).   
One website that CHF patients might commonly use to learn more about their condition 
is WedMD. In an article titled “Heart Failure and a Low-Salt Diet” it discusses the amount of 
sodium that patients with CHF should consume daily (WebMD, 2014). People with CHF should 
limit their sodium intake to no more than 2,000 mg a day but that ideally they should consume 
less than 1,500 mg per day (WebMD, 2014). Another website that could be frequently visited by 
patients for advice about how much sodium they should ingest is MedlinePlus. In an article titled 
“Sodium in Diet” the authors suggest that people with high blood pressure should consume no 
more than 1,500 mg of sodium per day and that people with CHF may need even lower amounts 
of sodium daily (National Institute of Health [NIH], 2013b). There is a lack of consensus in the 
literature surrounding appropriate amounts of sodium for patients in all ACCF/ AHA stages of 
CHF. Therefore, further research needs to be conducted in order to devise definitive sodium 
restriction levels. This lack of consensus could cause patients to consume too much or too little 
sodium both of which affect their control over their disease process.  
External Memory Aids and Mnemonics 
External memory aids can be used to encourage a patient to act upon what is depicted in 
the aid. There are two categories of external memory aids passive and active reminders. Passive 
reminders include: calendars, diaries, lists, or post-it notes (McDonald et al., 2011). Passive 
reminders require the user to check them. Active reminders include pagers, computers, and 
mobile phones (McDonald et al., 2011). Active reminders prompt the user to complete a task at a 
specific time. Some researchers believe passive reminders may be more effective than active 
reminders because they allow the user to check things off once they are completed. Researchers 
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believe that memory aids assist individuals to encode, trigger, and retrieve their intentions 
(McDonald et al., 2011). McDonald et al. (2011) found that participants who suffered from brain 
injuries affecting their prospective memory (the process of being able to perform specific 
intentional actions in the future) who used memory aids were 15% more likely to complete the 
tasks they intended to perform. 
Robert Tobias (2009) has examined the results of changing behavior in individuals 
through the use of memory aids. Tobias (2009) believes that changing habitual behaviors has to 
do with a problem in memory. He asserts that behaviors can only be performed if they can be 
remembered without any effort on the part of the individual. This is why habits are hard to break 
because they take no memory to perform the task that is engrained in one’s memory. Therefore, 
individuals must be reminded of new behaviors they need to perform in order to change their 
habitual behavior routines (Tobias, 2009).  
Tobias (2009) agrees that memory aids can increase an individual’s likelihood of 
performing a prospective memory task, such as taking a medication. He also mentions that when 
it comes to a memory aid that is used to elicit a person to take a medication, there should be a 
way to indicate on the aid if the task has been performed, so that the individual does not repeat it 
within a certain time period, which could be harmful as it pertains to medication adherence 
(Tobias, 2009). He asserts that the effectiveness of an external memory aid depends on the time 
and location of it. Tobias (2009) states that over time the effect of the memory aid fades and that 
the effect of the aid is also diminished the further the external memory aid is from the task that 
the individual needs to perform. If a memory aid can lead an individual to repeat behaviors, then 
over time they will become habitual. The amount of time it takes to form a repeated action into a 
habit is less than the amount of time that the external memory loses its saliency as a reminder. 
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Therefore, if an external memory aid elicits a behavior repeatedly, that behavior will turn into a 
habit and eventually the memory aid will no longer be needed by the individual to perform the 
behavior (Tobias, 2009). Tobias (2009) does say that in order to perform a behavior enough 
times for it to be formed into a habit, it takes commitment and consistent action from the 
individual initially. If a behavior is performed more often and is converted into a habit it is more 
likely that, even under more stressful circumstances, the behavior will still be carried out. 
Location was another important factor examined by Tobias (2009) that has a major impact on the 
development of a behavior or action into a habit. If one puts the external memory aid in a 
location that is close to where the behavior needs to be performed then the likelihood that the 
behavior will be initiated increases (Tobias, 2009). 
Mnemonics can also be used as a memory aid to remember a list of things to do (Sterling, 
2009). In one study by Sterling (2009) the mnemonic RED FRAMES was devised to help 
healthcare professionals identify risk factors for pressure ulcers and how to prevent pressure 
ulcers from forming. The mnemonic was laminated and placed on the back of clinician’s badges 
to remind them of ways to prevent ulcers and assess for risk factors. The mnemonic was not 
intended to replace validated risk assessment tools but was a means to increase awareness of risk 
factors that could increase an individual’s vulnerability to obtaining a pressure ulcer and elicit 
action from the clinician to prevent their formation. A hospital wide campaign to increase 
awareness about the mnemonic was also initiated. A survey was conducted in 2007 prior to the 
hospital wide campaign found that the percentage of hospital acquired pressure ulcers at this 
facility was 56.3%. A second survey was conducted eight months after the introduction of the 
mnemonic and the percentage of hospital acquired pressure ulcers at this facility decreased to 
18.2 % (Sterling, 2009). 
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Recommendation 
 A visual aid, titled Daily Checklist, was created for CHF patients in order to improve 
their self-efficacy and ability to manage their disease (Appendix A). The visual aid is laminated 
and the patient would be given a dry-erase marker in order to use it each day. It would ideally go 
on the patient’s refrigerator or another area in the home where they would see it frequently 
throughout the day and where it would be close to the areas they would perform the components 
needed to manage their CHF. The checklist includes an encouraging phrase to empower patients 
to use the tool, “Helping my Heart to Stay Healthy.”  
 The main components of managing one’s heart failure are included in the Daily 
Checklist. These components include: medications, exercise, daily weight, and sodium 
(salt).They are listed in an order so that the first letters of each component spell out the 
mnemonic MEDS. This was done in an effort to increase the patient’s ability to memorize the 
daily components of managing their CHF. The first component is medications. Beside the word 
medications there are three spaces for the patient to check if they have taken their morning, 
evening, and night time medications. The next component listed in the Daily Checklist is 
exercise. Beside the words exercise there are two spaces that allow the patient to write what type 
of exercise they performed and the time they spent exercising. The next component is daily 
weight. Beside the words daily weight there is a space for the patient to write their weight in 
pounds for the day. Lastly on the checklist is sodium (salt). Beside these words there is a space 
for the patient to indicate how many milligrams of sodium they consumed throughout the day. 
Below the checklist portion of the visual aid there is a reminder that the patient should record the 
information from the checklist into a journal and take the journal with them to their next doctor’s 
visit. At the bottom there is space to allow the patient’s provider to indicate any other 
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recommendations that would specifically apply to that particular patient such as what 
medications they are taking and when to take them, how much exercise and what type of 
exercise they should perform, when to call them about weight increases or decreases, how much 
sodium they should consume daily or if they should restrict their fluid intake.  
 The Daily Checklist has pictures for each of the components listed. For the sodium 
content component there is a nutritional facts label that shows how to read a food label to know 
how much sodium is in each serving size and how many serving sizes are in a product. The font 
is large so that it is easy to read. The words used in the visual aid are relatively simple words that 
can easily be understood, even by those who have a low literacy level. The colors for the writing 
of the words are black and the background color is white and light gray in order to add contrast. 
This tool would be relatively inexpensive to make, it would only require the provider have access 
to a computer, printer, and machine to laminate the visual aid. A dry-erase marker would also 
need to be provided to the patient and a journal to record each day’s results. The hope is that by 
providing this Daily Checklist before discharge or upon diagnosis with CHF, patients could 
better manage their CHF. This would ultimately decrease readmission rates, improve HRQOL, 
prevent early mortality, and decrease the cost burden of CHF patients on the healthcare system.  
Implications for Future Practice 
 In the future, this tool would need to be tested with a population of CHF patients in order 
to identify how effective it is at increasing patient self-efficacy (their confidence in managing 
their disease) and perceived HRQOL. The patients would need to be evaluated before receiving 
the Daily Checklist to determine their confidence level and perceived HRQOL and then again 
after they have used the tool to determine if their self-efficacy and perceived HRQOL has 
improved. A longitudinal study would also need to be conducted. The patients who were given 
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the tool would need to be compared to a control group to determine if they experience fewer 
rates of readmission to the hospital due to CHF and a decreased mortality rate than those who did 
not receive and use the Daily Checklist.  
 In the future, the Daily Checklist could also be translated into different languages. This 
could allow for patients who do not speak English as their primary language to better manage 
their CHF. Similarly, this new tool would also need to be tested to find if patient self-efficacy 
increased and if readmission rates and mortality rates were decreased. 
 Additionally, more research needs to be conducted to determine appropriate sodium 
levels for the various stages of CHF. As of now, there are not definitive sodium 
recommendations for patients categorized in Stages C and D. In order for these patients to 
control their CHF symptoms and prevent readmissions and mortality, they need to be informed 
on how much sodium is appropriate for them. In addition to more research into the appropriate 
levels of sodium for CHF patients, there also needs to be research initiated to determine how 
much exercise is appropriate for patients in each stage of CHF.  
Summary 
 CHF is a condition that leads to over a million hospital admissions each year (Yancy et 
al., 2013). It is the number one reason for hospital admissions in people over the age of 65 
(Lambrinou, Kalogirou, Lamnisos, & Sourtzi, 2012). As America shifts toward an older 
demographic in the coming decades the number of people who live with CHF is expected to 
increase (Yancy et al., 2013). CHF has a major impact on those who are affected related to their 
HRQOL. They are also at increased risk for mortality (Yancy et al., 2013).  Not only does CHF 
affect the individual who has it, the cost for care and readmissions place an enormous financial 
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burden on the health care system (Yancy et al., 2013). Current strategies used to combat 
readmission rates have not proven to be enough to solve the issue (Bradley et al., 2012).  
There are several factors that can be examined as contributing to why readmission rates 
are high in this population. One area that seems to be promising in helping to prevent high 
readmission rates for CHF is the activation of the patient’s self-efficacy in their ability to manage 
their disease process (Shively et al., 2013). The Daily Checklist should be given to every patient 
when they are first diagnosed with CHF or upon discharge from the hospital. In conjunction with 
the current practices used to prevent readmissions, the Daily Checklist can help to instill 
confidence in the patient that their CHF is manageable if they take the necessary measures to 
control their health and wellness. The Daily Checklist will act as a reminder to the patient about 
the necessary steps that must be completed each day in order for them to prevent readmissions to 
the hospital, early mortality, and to improve their overall HRQOL.  
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